Study guide

6.2 Inborn Errors of Metabolism

Board Certified Specialist in Pediatric Nutrition CSP

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 CSP Exam Facts, Format & Fees 1.2 Eligibility & Application Process 1.3 Scoring, Test Day Logistics & Study Strategy

2 Pediatric Growth & Development

2.1 Growth Patterns Across Pediatric Age Bands 2.2 Developmental Milestones & Feeding Skill Acquisition

3 Human Milk & Infant Formulas

3.1 Human Milk & Lactation Management 3.2 Milk Handling, Storage, Donor Milk & Fortification 3.3 Infant & Specialized Formulas

4 Age-Appropriate Nutrition & Foods

4.1 Complementary Feeding & Toddler Nutrition 4.2 School-Age & Adolescent Nutrition

5 Prematurity & the NICU Graduate

5.1 Preterm Nutrition in the NICU 5.2 Post-Discharge Nutrition for Preterm Infants

6 Congenital, Developmental & Metabolic Conditions

6.1 Congenital & Neurodevelopmental Conditions 6.2 Inborn Errors of Metabolism

7 GI Disorders & Food Allergy

7.1 Gastrointestinal Disorders: IBD, Celiac, Short Bowel & GERD 7.2 Food Allergy, FPIES & Eosinophilic Esophagitis

8 Body System & Organ Dysfunction

8.1 Cystic Fibrosis & Respiratory Support 8.2 Congenital Heart Disease & Cardiac Conditions 8.3 Chronic Kidney Disease, Dialysis & Transplant

9 Oncology, Endocrine & Weight-Related Care

9.1 Pediatric Oncology & HSCT Nutrition 9.2 Diabetes Management & Ketogenic Diet Therapy 9.3 Pediatric Overweight & Obesity (AAP 2023 Guideline) 9.4 Eating Disorders, ARFID & Pediatric Feeding Disorder

10 Clinical Status & Health History

10.1 Medical Treatment & Medication History 10.2 Nutrition & Supplementation History 10.3 Cultural & Psychosocial Factors 10.4 Activity & Lifestyle History 10.5 Birth, Perinatal & Surgical History

11 Anthropometrics & Growth Assessment

11.1 Anthropometric Measurement Techniques 11.2 Growth Charts & Z-Score Interpretation 11.3 Growth Assessment in Preterm & Special Populations 11.4 Pediatric Malnutrition: AND/ASPEN Consensus Criteria 11.5 Body Composition Assessment in Children

12 Physical Exam, Laboratory Data & Nutrition Diagnosis

12.1 Nutrition-Focused Physical Exam 12.2 Diagnostic & Laboratory Testing 12.3 Micronutrient Status Assessment & Deficiency Workup 12.4 Gastrointestinal Function & Diagnostic Testing 12.5 Nutrition Diagnosis, PES Statements & the NCP

13 Estimation of Nutritional Needs

13.1 Energy Needs Across Age & Clinical State 13.2 Protein & Fluid Requirements 13.3 Micronutrient Needs & Catch-Up Growth 13.4 Estimating Needs in Critical Illness & Special Clinical States

14 Oral Nutrition & Supplementation

14.1 Oral Nutrition & Therapeutic Diet Modification 14.2 Texture Modification & Dysphagia Management 14.3 Vitamin & Mineral Supplementation

15 Enteral Nutrition Support

15.1 Enteral Nutrition: Indications & Access 15.2 Enteral Formula Selection 15.3 Feeding Regimens, Advancement & Complications

16 Parenteral Nutrition Support

16.1 PN Indications & Composition 16.2 PN Initiation, Advancement & Monitoring 16.3 PN Complications & IFALD

17 Care Planning, Coordination & Education

17.1 Monitoring & Evaluation of Nutrition Care 17.2 Interdisciplinary Coordination & Transitions of Care 17.3 Access to Food & Healthcare: Federal Programs 17.4 Education & Counseling for Children & Families 17.5 Documentation, Quality & Outcomes in Pediatric Nutrition Care 17.6 Ethics, Palliative Care & Nutrition Decision-Making

6.2 Inborn Errors of Metabolism

Key Takeaways Explain This Topic AI

Newborn screening uses dried blood spots collected at 24-48 hours of life; tandem mass spectrometry screens dozens of disorders from one specimen

PKU treatment is a lifelong phenylalanine-restricted diet with blood Phe targets of 120-360 umol/L (2-6 mg/dL); a Phe-free medical formula supplies the majority of protein, and maternal PKU demands strict preconception control

During illness, children with MSUD and fatty acid oxidation defects follow sick-day protocols that preserve calories and specialized formula while suppressing catabolism; severe decompensation may require hemodialysis

Hyperammonemia is an emergency: stop protein intake, give IV glucose and lipids to halt catabolism, start nitrogen-scavenging medications, and dialyze if severe

Glycogen storage disease type I is managed with frequent feeds and uncooked cornstarch to prevent hypoglycemia, with galactose and fructose restricted

Last updated: August 2026

Newborn Screening: The Entry Point

Nearly every inborn error of metabolism (IEM) a pediatric dietitian will manage enters care through newborn screening . A dried blood spot is collected at 24-48 hours of life (screening before 24 hours produces false negatives for some conditions, and specimens from preterm or transfused infants may need repeating). Tandem mass spectrometry (MS/MS) revolutionized the field by measuring dozens of amino acids and acylcarnitines from a single spot, enabling one test to screen for phenylketonuria, maple syrup urine disease, many organic acidemias, and fatty acid oxidation defects. The Recommended Uniform Screening Panel now includes dozens of core conditions, though state panels vary. A positive screen triggers confirmatory testing and immediate referral to a metabolic center, because for most of these disorders early dietary treatment prevents irreversible neurologic injury .

Phenylketonuria

Phenylketonuria (PKU) results from deficiency of phenylalanine hydroxylase (PAH) , which converts phenylalanine (Phe) to tyrosine. Untreated, accumulating Phe causes severe intellectual disability; treated from the newborn period, outcomes are excellent. Management principles:

Phenylalanine-restricted diet for life : natural protein is counted in milligrams of Phe (or exchanges), with most fruits, vegetables, and low-protein specialty products forming the diet base. High-protein foods (meat, dairy, eggs, nuts, grains in quantity) are largely excluded.

Medical formula : a Phe-free amino acid-based protein substitute supplies the majority (often 80% or more) of protein needs; because tyrosine cannot be synthesized, tyrosine becomes conditionally essential and is supplied by the formula.

Blood Phe targets : the widely cited ACMG treatment target is 120-360 umol/L (2-6 mg/dL) across ages, monitored by regular blood spots.

Aspartame (an artificial sweetener containing phenylalanine) must be avoided.

Maternal PKU : elevated maternal Phe is teratogenic, causing fetal microcephaly, congenital heart disease, growth restriction, and intellectual disability even when the fetus does not have PKU. Women must achieve strict metabolic control before conception and maintain it throughout pregnancy.

Pharmacotherapy : sapropterin dihydrochloride (Kuvan) , a synthetic form of the BH4 cofactor, lowers Phe in a responsive subset (more often mild phenotypes); pegvaliase (Palynziq) , an enzyme-substitution injection approved for adults, can normalize Phe and liberalize the diet but carries anaphylaxis risk requiring risk-management protocols.

Maple Syrup Urine Disease

Maple syrup urine disease (MSUD) is caused by deficiency of the branched-chain alpha-ketoacid dehydrogenase complex, so the branched-chain amino acids leucine, isoleucine, and valine accumulate (leucine is the neurotoxin; the urine smells of maple syrup or burnt sugar). Chronic management restricts natural protein to titrate leucine to target plasma levels while a BCAA-free medical food supplies the remaining protein, plus isoleucine and valine supplementation as needed to keep them sufficient. The highest-stakes skill is the sick-day protocol : intercurrent illness triggers catabolism, which floods the blood with leucine from endogenous protein breakdown. Families are taught to reduce natural protein, keep the BCAA-free formula and high-calorie carbohydrates flowing, and seek immediate care for vomiting, lethargy, or ataxia. In-hospital crises are treated with IV glucose (often with insulin) and lipids to shut down catabolism; severe leucine elevation with encephalopathy may require hemodialysis . Liver transplantation halts crises and is an option in classic disease.

Urea Cycle Disorders

In urea cycle disorders (UCD) , the liver cannot convert ammonia to urea; ornithine transcarbamylase (OTC) deficiency , an X-linked disorder, is the most common. Chronic management combines:

Protein restriction matched to age and residual enzyme activity, sometimes with essential amino acid formula.

Citrulline or arginine supplementation to replace urea cycle intermediates downstream of the block (arginine becomes essential in most UCDs).

Nitrogen-scavenging medications : sodium benzoate and sodium phenylbutyrate (or glycerol phenylbutyrate) divert nitrogen into alternative excretion pathways.

The hyperammonemia emergency protocol is a must-know: stop all protein intake immediately , give IV glucose (D10) with or without insulin plus IV lipids to reverse catabolism, start IV nitrogen scavengers, and use hemodialysis for severe or refractory hyperammonemia. Protein is reintroduced within about 24-48 hours, because prolonged protein withdrawal itself drives catabolism.

Classic Galactosemia

Classic galactosemia (galactose-1-phosphate uridyltransferase, GALT, deficiency) makes dietary galactose toxic. Treatment is immediate and lifelong elimination of lactose and galactose: in infancy this means soy-based formula (breast milk and standard cow's-milk formulas contain lactose), followed by lifelong dairy avoidance with careful label reading. Calcium and vitamin D adequacy must be engineered from substitutes. Critically for counseling, long-term complications occur despite diet : speech and language deficits, learning differences, tremor/ataxia, and primary ovarian insufficiency in most females.

Fatty Acid Oxidation Disorders

In medium-chain acyl-CoA dehydrogenase (MCAD) deficiency , the most common fatty acid oxidation defect, fasting depletes glucose and the body cannot mobilize medium-chain fat for energy, risking hypoketotic hypoglycemia, encephalopathy, and death. The dietary prescription is deceptively simple: avoid fasting . Infants feed frequently with age-appropriate overnight fasting limits, and any illness with poor intake or vomiting triggers an emergency protocol of glucose-containing fluids and immediate evaluation. Medium-chain triglyceride oil is avoided, and routine carnitine supplementation is controversial (secondary carnitine depletion argues for it; acylcarnitine accumulation argues against), so practice varies by center.

Glycogen Storage Disease Type I

Glycogen storage disease type I (GSD I, von Gierke disease) is glucose-6-phosphatase deficiency: the liver stores glycogen but cannot release glucose, so hypoglycemia develops within a few hours of fasting. Management is nutritional engineering of a continuous glucose supply: frequent daytime feeds every 2-4 hours, scheduled doses of uncooked cornstarch (a slow-release glucose polymer), and continuous overnight tube feeds in infants. Because fructose and galactose cannot be converted to glucose and instead drive lactate, uric acid, and triglyceride production, sucrose, fruit (fructose), and lactose (galactose) are restricted .

Homocystinuria and Mitochondrial Disorders

Classical homocystinuria (cystathionine beta-synthase deficiency) is treated with a methionine-restricted diet (cystine becomes conditionally essential) plus a methionine-free medical food; roughly half of patients are pyridoxine (vitamin B6)-responsive and can relax restriction, while betaine lowers homocysteine and B12/folate support remethylation in related defects. Mitochondrial disorders have no single evidence-based diet: practical principles include avoiding prolonged fasting and catabolic stress; mitochondrial cocktails (coenzyme Q10, riboflavin, and others) are used despite limited evidence, and ketogenic diets are reserved for selected epilepsy phenotypes under close supervision.

Comparison of Major Inborn Errors

Disorder Enzyme defect Core dietary treatment Crisis management

PKU Phenylalanine hydroxylase Phe-restricted diet, Phe-free formula, Phe target 120-360 umol/L Liberalize calories; adjust Phe intake

MSUD Branched-chain ketoacid dehydrogenase Leucine-restricted diet, BCAA-free medical food Sick-day calories; IV glucose; hemodialysis if encephalopathic

Urea cycle disorders Urea cycle enzymes (e.g., OTC) Protein restriction, arginine/citrulline, nitrogen scavengers Stop protein, IV glucose/lipids, scavengers, dialysis

Classic galactosemia GALT Lifelong lactose/galactose-free; soy formula in infancy Immediate galactose removal at diagnosis

MCAD deficiency Medium-chain acyl-CoA dehydrogenase Avoid fasting; frequent feeds Glucose-containing fluids; emergency department if not tolerating intake

GSD type I Glucose-6-phosphatase Frequent feeds, uncooked cornstarch; restrict galactose/fructose IV glucose for hypoglycemia

General IEM Diet Principles

Across disorders the pattern is constant: identify the blocked pathway, restrict the nutrient upstream of the block, and replace what the restriction removes. Medical foods (amino acid formulas missing Phe, BCAA, or methionine) supply protein without the offending nutrient; natural protein is counted in milligrams or exchanges; and metabolic crisis prevention during catabolic stress (illness, surgery, fasting) with written sick-day plans is as important as the daily diet. Growth, bone health, and micronutrient status are monitored lifelong, with planned transition from pediatric to adult metabolic care.